Roger Newcomb

Roger Newcomb has worked as a Research and Development Scientist at AmbioPharm since January 2019. Prior to that, they worked as a Research and Development Chemist 2 at PolyPeptide Group from June 2010 to December 2018.

From 2004 to 2008, Roger Newcomb attended California State University-Dominguez Hills, where they pursued a Bachelor of Science degree in Nuclear Physics.